Given the epidemiological data showing that LS patients are protected from cancer development (45), we hypothesized that (1): the ZYG11A gene might be negatively regulated by ambient IGF1 levels; and (2) ZYG11A might fulfill a protective, anti-proliferative role, at least in certain types of cancer. This evidence concerns the gene IGF1 and cancer.